As medicinal science progresses, researchers have developed an AI mechanism that uses a selfie to determine a patient's ...

The researchers found that cancer patients tend to have a higher biological age as predicted by FaceAge compared to their ...

Tacrolimus outshined another immunosuppressive drug at extending relapse-free survival in kids with frequently relapsing or ...

The new test focuses on mutations in the NPM1 and FLT3 genes, which are among the most common causes of leukemia in younger ...

The comprehensive study, which tracked data spanning 20 years, revealed that not only does pregnancy not negatively impact ...

Researchers sought to determine whether combination therapy with zanubrutinib, obinutuzumab, and venetoclax would be effective for TP53-mutant MCL.

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...

Immutep said a treatment it is developing showed strong results in overall survival among head and neck cancer patients. The Australian cancer-treatment company said Monday the median rate for overall ...